Loading...
Header Logo
Keywords
Last Name
Institution

Michael Stuart Bronze

TitleProf,David R Boyd & Chair
InstitutionUniversity of Oklahoma Health Sciences Center
DepartmentDepartment of Medicine
Address800 Stanton L Young Blvd
Oklahoma City OK 73104-0001
Phone405/271-6655
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Chandrakesan P, May R, Weygant N, Qu D, Berry WL, Sureban SM, Ali N, Rao C, Huycke M, Bronze MS, Houchen CW. Intestinal tuft cells regulate the ATM mediated DNA Damage response via Dclk1 dependent mechanism for crypt restitution following radiation injury. Sci Rep. 2016 Nov 23; 6:37667. PMID: 27876863.
      View in: PubMed
    2. Weygant N, Ge Y, Qu D, Kaddis JS, Berry WL, May R, Chandrakesan P, Bannerman-Menson E, Vega KJ, Tomasek JJ, Bronze MS, An G, Houchen CW. Survival of Patients with Gastrointestinal Cancers Can Be Predicted by a Surrogate microRNA Signature for Cancer Stem-like Cells Marked by DCLK1 Kinase. Cancer Res. 2016 07 15; 76(14):4090-9. PMID: 27287716.
      View in: PubMed
    3. Nguyen CB, Kotturi H, Waris G, Mohammed A, Chandrakesan P, May R, Sureban S, Weygant N, Qu D, Rao CV, Dhanasekaran DN, Bronze MS, Houchen CW, Ali N. (Z)-3,5,4'-Trimethoxystilbene Limits Hepatitis C and Cancer Pathophysiology by Blocking Microtubule Dynamics and Cell-Cycle Progression. Cancer Res. 2016 Aug 15; 76(16):4887-96. PMID: 27287718; PMCID: PMC4987271 [Available on 08/15/17].
    4. Chandrakesan P, May R, Qu D, Weygant N, Taylor VE, Li JD, Ali N, Sureban SM, Qante M, Wang TC, Bronze MS, Houchen CW. Dclk1+ small intestinal epithelial tuft cells display the hallmarks of quiescence and self-renewal. Oncotarget. 2015 Oct 13; 6(31):30876-86. PMID: 26362399; PMCID: PMC4741574.
    5. Ali N, Chandrakesan P, Nguyen CB, Husain S, Gillaspy AF, Huycke M, Berry WL, May R, Qu D, Weygant N, Sureban SM, Bronze MS, Dhanasekaran DN, Houchen CW. Inflammatory and oncogenic roles of a tumor stem cell marker doublecortin-like kinase (DCLK1) in virus-induced chronic liver diseases. Oncotarget. 2015 Aug 21; 6(24):20327-44. PMID: 25948779; PMCID: PMC4653008.
    6. Kanwar A, Hawkins BM, Jackson RL, Koehler M, Bronze MS. Journey of a strut: from filter to missile. Am J Med Sci. 2015 Jan; 349(1):92-3. PMID: 25437126.
      View in: PubMed
    7. Patel N, Bronze MS. Histoplasma infection of aortofemoral bypass graft. Am J Med Sci. 2014 May; 347(5):421-4. PMID: 23928546.
      View in: PubMed
    8. Ali N, Allam H, Bader T, May R, Basalingappa KM, Berry WL, Chandrakesan P, Qu D, Weygant N, Bronze MS, Umar S, Janknecht R, Sureban SM, Huycke M, Houchen CW. Fluvastatin interferes with hepatitis C virus replication via microtubule bundling and a doublecortin-like kinase-mediated mechanism. PLoS One. 2013; 8(11):e80304. PMID: 24260365; PMCID: PMC3833963.
    9. Ali T, Chakraburtty A, Mahmood S, Bronze MS. Risk of nocardial infections with anti-tumor necrosis factor therapy. Am J Med Sci. 2013 Aug; 346(2):166-8. PMID: 23531994.
      View in: PubMed
    10. Ali T, Kaitha S, Mahmood S, Ftesi A, Stone J, Bronze MS. Clinical use of anti-TNF therapy and increased risk of infections. Drug Healthc Patient Saf. 2013; 5:79-99. PMID: 23569399; PMCID: PMC3615849.
    11. Patel BC, Wayangankar SA, Ngo E, Chakrabarty S, Bronze MS. Primary retroperitoneal abscess caused by Candida glabrata. Am J Med Sci. 2012 Oct; 344(4):332-4. PMID: 22739567.
      View in: PubMed
    12. Smith M, Harrison D, Ripley T, Grace S, Bronze MS, Jackson R. Warfarin management using point-of-care testing in a university-based internal medicine resident clinic. Am J Med Sci. 2012 Oct; 344(4):289-93. PMID: 22314105.
      View in: PubMed
    13. Ali T, Yun L, Shapiro D, Madhoun MF, Bronze M. Viral infections in patients with inflammatory bowel disease on immunosuppressants. Am J Med Sci. 2012 Mar; 343(3):227-32. PMID: 22357111.
      View in: PubMed
    14. Ali N, Allam H, May R, Sureban SM, Bronze MS, Bader T, Umar S, Anant S, Houchen CW. Hepatitis C virus-induced cancer stem cell-like signatures in cell culture and murine tumor xenografts. J Virol. 2011 Dec; 85(23):12292-303. PMID: 21937640; PMCID: PMC3209402.
    15. Wayangankar SA, Golwala H, Bronze MS. Refractory hypoxia in an HIV-infected patient--a diagnostic challenge. Am J Emerg Med. 2012 Sep; 30(7):1322.e5-6. PMID: 21871757.
      View in: PubMed
    16. Bronze MS. Southern Society for Clinical Investigation Founders' Medal acceptance. Am J Med Sci. 2011 Aug; 342(2):97-8. PMID: 21795949.
      View in: PubMed
    17. Weinberger SE, Pereira AG, Iobst WF, Mechaber AJ, Bronze MS. Internal medicine residency redesign. Ann Intern Med. 2011 Mar 15; 154(6):442-3. PMID: 21403084.
      View in: PubMed
    18. Weinberger SE, Pereira AG, Iobst WF, Mechaber AJ, Bronze MS. Competency-based education and training in internal medicine. Ann Intern Med. 2010 Dec 07; 153(11):751-6. PMID: 21135298.
      View in: PubMed
    19. Bronze MS, Dale JB. Progress in the development of effective vaccines to prevent selected gram-positive bacterial infections. Am J Med Sci. 2010 Sep; 340(3):218-25. PMID: 20697258; PMCID: PMC2935929.
    20. Greenfield RA, Bronze MS. Emerging pathogens and knowledge in infectious diseases. Am J Med Sci. 2010 Sep; 340(3):177-80. PMID: 20697260.
      View in: PubMed
    21. Fleckenstein JM, Bartels SR, Drevets PD, Bronze MS, Drevets DA. Infectious agents of food- and water-borne illnesses. Am J Med Sci. 2010 Sep; 340(3):238-46. PMID: 20823701.
      View in: PubMed
    22. Gaitán JI, Bronze MS. Infection caused by Rahnella aquatilis. Am J Med Sci. 2010 Jun; 339(6):577-9. PMID: 20545014.
      View in: PubMed
    23. Blevins SM, Bronze MS. Robert Koch and the 'golden age' of bacteriology. Int J Infect Dis. 2010 Sep; 14(9):e744-51. PMID: 20413340.
      View in: PubMed
    24. Madhoun MF, Fazili J, Bright BC, Bader T, Roberts DN, Bronze MS. Hepatitis C prevalence in patients with hepatocellular carcinoma without cirrhosis. Am J Med Sci. 2010 Feb; 339(2):169-73. PMID: 20087166.
      View in: PubMed
    25. Ali T, Lam D, Bronze MS, Humphrey MB. Osteoporosis in inflammatory bowel disease. Am J Med. 2009 Jul; 122(7):599-604. PMID: 19559158; PMCID: PMC2894700.
    26. Shakir F, Dang V, Bronze MS, Liu C, Machado L. Mycobacterium bovis infection of an axillary-femoral bypass graft after intravesical bacille Calmette-Guérin immunotherapy for bladder cancer. Am J Med Sci. 2009 Jan; 337(1):63-4. PMID: 18941407.
      View in: PubMed
    27. Drevets DA, Schawang JE, Dillon MJ, Lerner MR, Bronze MS, Brackett DJ. Innate responses to systemic infection by intracellular bacteria trigger recruitment of Ly-6Chigh monocytes to the brain. J Immunol. 2008 Jul 01; 181(1):529-36. PMID: 18566419.
      View in: PubMed
    28. Blevins SM, Greenfield RA, Bronze MS. Blood smear analysis in babesiosis, ehrlichiosis, relapsing fever, malaria, and Chagas disease. Cleve Clin J Med. 2008 Jul; 75(7):521-30. PMID: 18646588.
      View in: PubMed
    29. Drevets DA, Bronze MS. Listeria monocytogenes: epidemiology, human disease, and mechanisms of brain invasion. FEMS Immunol Med Microbiol. 2008 Jul; 53(2):151-65. PMID: 18462388.
      View in: PubMed
    30. Jackson R, Toubia N, Dhaliwal G, Bottomley SS, Bronze MS. A confusing case of confusion. Acute porphyrias. J Okla State Med Assoc. 2008 Apr; 101(4):85-6, 89-90. PMID: 18557584.
      View in: PubMed
    31. Stephens JR, Rathbun RC, Lockhart SM, Bronze MS, Greenfield RA. Part XV. Antiretroviral therapy for human immunodeficiency virus infection. J Okla State Med Assoc. 2007 Nov; 100(11):417-24. PMID: 18183858.
      View in: PubMed
    32. Ali T, Greenfield RA, Scofield H, Bronze MS. Gatifloxacin-associated hypoglycemia. J Okla State Med Assoc. 2007 Nov; 100(11):425-8. PMID: 18183859.
      View in: PubMed
    33. Smith BJ, Lightfoot SA, Lerner MR, Denson KD, Morgan DL, Hanas JS, Bronze MS, Postier RG, Brackett DJ. Induction of cardiovascular pathology in a novel model of low-grade chronic inflammation. Cardiovasc Pathol. 2009 Jan-Feb; 18(1):1-10. PMID: 18402801.
      View in: PubMed
    34. Lockhart SM, Salvaggio MR, Bronze MS, Greenfield RA. Part XIV. Antiviral agents other than antiretrovirals: therapy for herpesvirus infections, viral hepatitis, and influenza. J Okla State Med Assoc. 2007 Oct; 100(10):388-95. PMID: 18085096.
      View in: PubMed
    35. Busse KH, Gentry CA, Bronze MS, Greenfield RA. Part XIII. Systemic antifungal therapy. J Okla State Med Assoc. 2007 Sep; 100(9):344-51. PMID: 18020039.
      View in: PubMed
    36. Sud B, Salvaggio M, Greenfield R, Greenfield RA, Bronze MS. Part XI. Trimethoprim-sulfamethoxazole, nitrofurantoin, chloramphenicol, metronidazole and tinidazole, rifaximin, and nitazoxanide. J Okla State Med Assoc. 2007 Jul; 100(7):267-72. PMID: 17896614.
      View in: PubMed
    37. Vincent S, Bronze MS, Cooper TW, Greenfied RA. Part X. Tetracycline and glycylcycline antimicrobials. J Okla State Med Assoc. 2007 Jun; 100(6):241-7. PMID: 17708423.
      View in: PubMed
    38. Vincent S, Machado L, Cooper TW, Bronze MS, Greenfield RA. Part IX. Quinolone antimicrobials. J Okla State Med Assoc. 2007 May; 100(5):149-56. PMID: 17557602.
      View in: PubMed
    39. Hoffman-Roberts HL, Obritsch MD, Bronze MS, Greenfield RA. Antimicrobial symposium. Part VIII. Glycopeptides, oxazolidinones, and lipopeptides. J Okla State Med Assoc. 2007 Apr; 100(4):105-11. PMID: 17476993.
      View in: PubMed
    40. Dang V, Nanda N, Cooper TW, Greenfield RA, Bronze MS. Part VII. Macrolides, azalides, ketolides, lincosamides, and streptogramins. J Okla State Med Assoc. 2007 Mar; 100(3):75-81. PMID: 17432033.
      View in: PubMed
    41. Nanda N, Dang V, Cooper TW, Bronze MS, Greenfield RA. Antimicrobial symposium. Part VI. Aminoglycosides and polymyxins. J Okla State Med Assoc. 2007 Feb; 100(2):60-4. PMID: 17393675.
      View in: PubMed
    42. Gibbs WJ, Cooper TW, Bronze MS, Greenfield RA. Part V. Other beta-lactam antimicrobials. J Okla State Med Assoc. 2007 Jan; 100(1):23-5. PMID: 17378498.
      View in: PubMed
    43. Cooper TW, Gibbs WJ, Bronze MS, Greenfield RA. Antimicrobial symposium. Part IV. Cephalosporins. J Okla State Med Assoc. 2006 Dec; 99(12):579-83. PMID: 17310925.
      View in: PubMed
    44. Gibbs WJ, Cooper TW, Bronze MS, Greenfield RA. Part III. Penicillins. J Okla State Med Assoc. 2006 Nov; 99(11):551-6. PMID: 17191689.
      View in: PubMed
    45. Cooper TW, Gibbs WJ, Bronze MS, Greenfield RA. Part II. Introduction to the beta-lactam antibiotics. J Okla State Med Assoc. 2006 Oct; 99(10):516-20. PMID: 17125105.
      View in: PubMed
    46. Greenfield RA, Cooper TW, Bronze MS. Antimicrobial symposium. Part 1. Principles of antimicrobial therapy. J Okla State Med Assoc. 2006 Sep; 99(9):474-9. PMID: 17087070.
      View in: PubMed
    47. Bronze MS. Address of the president of the Southern Society for Clinical Investigation: on the importance of mentoring. Am J Med Sci. 2005 Nov; 330(5):209-12. PMID: 16284478.
      View in: PubMed
    48. Sawalha AH, Saint S, Ike RW, Bronze MS. Clinical problem-solving. Still consider the source. N Engl J Med. 2005 Oct 06; 353(14):1503-7. PMID: 16207853.
      View in: PubMed
    49. Foote EA, Postier RG, Greenfield RA, Bronze MS. Infectious Aortitis. Curr Treat Options Cardiovasc Med. 2005 Jun; 7(2):89-97. PMID: 15935117.
      View in: PubMed
    50. Jackson RL, Bronze MS. Overview and management of obesity in adults. J Okla State Med Assoc. 2004 Oct; 97(10):422-6. PMID: 15552238.
      View in: PubMed
    51. Greenfield RA, Bronze MS. Current therapy and the development of therapeutic options for the treatment of diseases due to bacterial agents of potential biowarfare and bioterrorism. Curr Opin Investig Drugs. 2004 Feb; 5(2):135-40. PMID: 15043386.
      View in: PubMed
    52. Sawalha AH, Bronze MS, Saint S, Blevins S, Kern W. Clinical problem-solving. Step by step. N Engl J Med. 2003 Dec 04; 349(23):2253-7. PMID: 14657433.
      View in: PubMed
    53. Bronze MS, Huycke MM, Greenfield RA. Terrorism symposium update and conclusion. J Okla State Med Assoc. 2003 Dec; 96(12):575-8. PMID: 14965028.
      View in: PubMed
    54. Greenfield RA, Bronze MS. Prevention and treatment of bacterial diseases caused by bacterial bioterrorism threat agents. Drug Discov Today. 2003 Oct 01; 8(19):881-8. PMID: 14554016.
      View in: PubMed
    55. Bronze MS, Greenfield RA. Preventive and therapeutic approaches to viral agents of bioterrorism. Drug Discov Today. 2003 Aug 15; 8(16):740-5. PMID: 12944096.
      View in: PubMed
    56. Voskuhl GW, Cornea P, Bronze MS, Greenfield RA. Other bacterial diseases as a potential consequence of bioterrorism: Q fever, brucellosis, glanders, and melioidosis. J Okla State Med Assoc. 2003 May; 96(5):214-7. PMID: 12833721.
      View in: PubMed
    57. Bronze MS, Greenfield RA. Therapeutic options for diseases due to potential viral agents of bioterrorism. Curr Opin Investig Drugs. 2003 Feb; 4(2):172-8. PMID: 12669378.
      View in: PubMed
    58. Lutz BD, Bronze MS, Greenfield RA. Influenza virus: natural disease and bioterrorism threat. J Okla State Med Assoc. 2003 Jan; 96(1):27-8. PMID: 12632850.
      View in: PubMed
    59. Bronze MS, Voskuhl GW, Machado LJ, Greenfield RA. The potential role of viral pathogens as agents of bioterrorism. J Okla State Med Assoc. 2003 Jan; 96(1):29-33. PMID: 12632851.
      View in: PubMed
    60. Greenfield RA, Bronze MS. Symposium introduction: clinical aspects of terrorism. J Okla State Med Assoc. 2002 Sep; 95(9):583-6. PMID: 12362647.
      View in: PubMed
    61. Evans RG, Crutcher JM, Shadel B, Clements B, Bronze MS. Terrorism from a public health perspective. Am J Med Sci. 2002 Jun; 323(6):291-8. PMID: 12074484.
      View in: PubMed
    62. Greenfield RA, Drevets DA, Machado LJ, Voskuhl GW, Cornea P, Bronze MS. Bacterial pathogens as biological weapons and agents of bioterrorism. Am J Med Sci. 2002 Jun; 323(6):299-315. PMID: 12074485.
      View in: PubMed
    63. Bronze MS, Huycke MM, Machado LJ, Voskuhl GW, Greenfield RA. Viral agents as biological weapons and agents of bioterrorism. Am J Med Sci. 2002 Jun; 323(6):316-25. PMID: 12074486.
      View in: PubMed
    64. Greenfield RA, Brown BR, Hutchins JB, Iandolo JJ, Jackson R, Slater LN, Bronze MS. Microbiological, biological, and chemical weapons of warfare and terrorism. Am J Med Sci. 2002 Jun; 323(6):326-40. PMID: 12074487.
      View in: PubMed
    Bronze's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Physical Neighbors Expand Description
    _